Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-004839
Filing Date
2017-05-08
Accepted
2017-05-08 12:56:40
Documents
33
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 292162
2 ex31-1.htm EX-31.1 11518
3 ex31-2.htm EX-31.2 12605
4 ex32-1.htm EX-32.1 5822
5 image_01.jpg GRAPHIC 9992
  Complete submission text file 0001493152-17-004839.txt   963881

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vapa-20170331.xml EX-101.INS 53152
7 XBRL SCHEMA FILE vapa-20170331.xsd EX-101.SCH 13739
8 XBRL CALCULATION FILE vapa-20170331_cal.xml EX-101.CAL 20214
9 XBRL DEFINITION FILE vapa-20170331_def.xml EX-101.DEF 27223
10 XBRL LABEL FILE vapa-20170331_lab.xml EX-101.LAB 93491
11 XBRL PRESENTATION FILE vapa-20170331_pre.xml EX-101.PRE 68698
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 17821439
SIC: 2834 Pharmaceutical Preparations